Wall Street’s main indexes fell on Friday, while investors assessed the impact of a global cyber outage that knocked down CrowdStrike’s shares to an over two-month low.
Read More Wall Street extends rout, CrowdStrike slumps on global tech outage
Tag: Eli Lilly
Donanemab, Eli Lilly’s Early Alzheimer’s Disease Treatment Approved By FDA
Donanemab is a monoclonal antibody that the U.S. Food and Drug Administration (FDA) approved on Tuesday with the goal of slowing the progression of early-stage symptomatic Alzheimer’s disease.
Read More Donanemab, Eli Lilly’s Early Alzheimer’s Disease Treatment Approved By FDA
Wall St gains from megacaps thrust; earnings, Fed comments on tap
Wall Street’s main indexes rose on Wednesday, boosted by megacap growth stocks and as corporate results rolled in.
Read More Wall St gains from megacaps thrust; earnings, Fed comments on tap
Eli Lilly’s obesity drug now available in U.S. pharmacies
Eli Lilly said its recently approved obesity treatment Zepbound is now available in U.S. pharmacies.
Read More Eli Lilly’s obesity drug now available in U.S. pharmacies
New Alzheimer’s Drug Slows Early Stages Of Disease
A new study revealed that Lilly Biotechnology Center’s Alzheimer’s drug slowed the disease by as much as 22% to 35%, compared to a separate placebo study.
Read More New Alzheimer’s Drug Slows Early Stages Of Disease